---
title: UK veterinary groups media reputation tracker – H1 2026
canonical_url: https://www.omniscan.ai/benchmarks/uk-veterinary-groups-2026-h1
type: dataset
publisher: Omniscan
sector: UK Veterinary Groups
period: H1 2026
coverage_start: '2026-01-01'
coverage_end: '2026-06-30'
date_published: '2026-09-01'
last_updated: '2026-09-01'
organisations: 6
articles_analysed: 846
mentions: 384
data_download: https://www.omniscan.ai/benchmarks/uk-veterinary-groups-2026-h1/data.json
summary: CVS Group had the highest average monthly share of coverage (29.6%) among
  6 groups in UK earned media from 1 January 2026 to 30 June 2026, ahead of IVC Evidensia
  (25.0%) and VetPartners (16.9%).
---

# UK veterinary groups media reputation tracker: H1 2026 (1 January 2026–30 June 2026)

> CVS Group had the highest average monthly share of coverage (29.6%) among 6 groups in UK earned media from 1 January 2026 to 30 June 2026, ahead of IVC Evidensia (25.0%) and VetPartners (16.9%). VetPartners had the most favourable net tone (+75). Omniscan analysed 846 articles containing 384 mentions of the groups tracked.

Interactive version: https://www.omniscan.ai/benchmarks/uk-veterinary-groups-2026-h1

## UK Veterinary Groups ranking by share of coverage, H1 2026

| Rank | Organisation | Average monthly share of coverage | Mentions | Positive | Neutral | Negative | Net tone |
| --- | --- | --- | --- | --- | --- | --- | --- |
| 1 | CVS Group | 29.6% | 119 | 56% | 36% | 8% | +49 |
| 2 | IVC Evidensia | 25.0% | 89 | 46% | 28% | 26% | +20 |
| 3 | VetPartners | 16.9% | 57 | 81% | 14% | 5% | +75 |
| 4 | Pets at Home Vet Group | 16.5% | 74 | 76% | 20% | 4% | +72 |
| 5 | Medivet | 10.4% | 38 | 55% | 16% | 29% | +26 |
| 6 | Linnaeus | 1.6% | 7 | 14% | 57% | 29% | −14 |

## Monthly share of coverage, UK Veterinary Groups

| Organisation | January 2026 | February 2026 | March 2026 | April 2026 | May 2026 | June 2026 |
| --- | --- | --- | --- | --- | --- | --- |
| CVS Group | 23.1% | 34.1% | 39.2% | 31.8% | 34.9% | 14.3% |
| IVC Evidensia | 20.0% | 39.0% | 25.5% | 20.5% | 8.4% | 36.7% |
| VetPartners | 16.9% | 14.6% | 6.9% | 25.0% | 9.6% | 28.6% |
| Pets at Home Vet Group | 32.3% | 2.4% | 19.6% | 9.1% | 31.3% | 4.1% |
| Medivet | 6.2% | 9.8% | 4.9% | 13.6% | 15.7% | 12.2% |
| Linnaeus | 1.5% | 0.0% | 3.9% | 0.0% | 0.0% | 4.1% |

## Groups in detail

### CVS Group

**CVS leads year to date as coverage shifts from finance to clinical**

CVS Group ranked 1st of 6 by average monthly share of coverage (29.6%) in the UK Veterinary Groups benchmark for H1 2026, with 119 mentions and a net tone of +49.

It began in second place in January and February, when reporting centred on interim performance, the Main Market move and new clinical programmes. March brought first place, 40 mentions and a 39.2% share alongside coverage of the CMA remedies, Richard Fairman’s planned retirement, a Bristol training centre and new oncology support. CVS remained first through April and May, although the agenda moved from Animed pricing articles and antimicrobial stewardship to activist pressure, refinancing, a £50 million buyback and Australian acquisitions. Its share then fell by 20.6 percentage points to 14.3% in June, placing it third, while stories included antibiotic stewardship results, equine safety training and a £1.4 million clinic investment. The largest measured increases occurred in March and May; stories in those months included leadership succession, the CMA remedies, activist pressure, refinancing, buybacks and acquisitions. Visibility peaked in March 2026 at 39.2%, compared with 14.3% in June 2026. January 2026: CVS launched its Life Stage Assessment Framework for preventative, tailored pet care, reported by Vet Times. May 2026: volume increased by 15 and share by 3.1 percentage points while CVS remained first; stories included Converium Capital’s £100 million buyback demand and CVS’s subsequent £50 million buyback and refinancing.

Key messages:

- Visibility peaked in March 2026 at 39.2%, compared with 14.3% in June 2026.
- January 2026: CVS launched its Life Stage Assessment Framework for preventative, tailored pet care, reported by Vet Times.
- CVS Group reported 5.8% revenue growth to £356.9 million and 3.9% adjusted EBITDA growth for the half year. It published a prospectus ahead of moving from AIM to the London Stock Exchange Main Market.
- CVS Group is sponsoring Pet Blood Bank UK's Heart of Pet Blood Bank awards for a second consecutive year. Its chief executive praised the charity's lifesaving work.
- CVS Group has launched and funded a three-year PhD to optimise veterinary nurses' roles in UK companion-animal practice. The project aims to improve nurse wellbeing, job satisfaction, patient care and workforce sustainability.
- CVS Farm Vets reported progress in its mastitis quality-improvement programme, including a 15% rise in diagnostic activity during 2025. The initiative uses on-site testing to support more targeted antibiotic prescribing across 15 farm practices.

Leading themes:

- Financial Results & Ownership: 31.1% of CVS Group's coverage (theme index 1.68, net tone +41)
- Clinical Standards & Pet Safety: 15.1% of CVS Group's coverage (theme index 0.59, net tone +89)
- CMA Remedies & Competition: 14.3% of CVS Group's coverage (theme index 1.31, net tone 0)

Notable positive coverage:

- 8 January 2026, vettimes.com: [CVS launches life stage assessment framework](https://www.vettimes.com/news/vets/small-animal-vets/cvs-launches-life-stage-assessment-framework). CVS Group is rolling out a Life Stage Assessment Framework to support preventative, tailored wellness care for cats and dogs. The initiative provides clinical tools, training and owner-education resources for veterinary teams.
- 23 January 2026, vettimes.com: [Sector remains 'strong', says CVS Group ahead of share switch](https://www.vettimes.com/news/business/finance/sector-remains-strong-says-cvs-group-ahead-of-share-switch). CVS Group reported 5.8% revenue growth to £356.9 million and 3.9% adjusted EBITDA growth for the half year. It published a prospectus ahead of moving from AIM to the London Stock Exchange Main Market.
- 12 February 2026, vettimes.com: [CVS launches collaborative care project to strengthen engagement with pet owners](https://www.vettimes.com/news/business/practice-developments/cvs-launches-collaborative-care-project). CVS Group launched its Collaborative Care Project to improve communication between veterinary teams and pet owners. The initiative aims to support clinical outcomes, client satisfaction and team resilience.

Notable negative coverage:

- 22 May 2026, independent.co.uk: [Vet wins over £12,000 after she was forced to work through her lunch breaks](https://www.independent.co.uk/news/uk/home-news/michelle-beckett-vet-pet-chichester-b2981778.html). An employment tribunal awarded a former CVS veterinary surgeon £12,758 after finding CVS had constructively dismissed her following excessive workloads, missed breaks and inadequate handling of work-related stress. The case also includes allegations of below-standard animal care at a CVS practice.
- 13 May 2026, reuters.com: [Activist Converium calls on UK vet group CVS to initiate stock buyback](https://www.reuters.com/sustainability/sustainable-finance-reporting/activist-converium-pushes-uks-cvs-improve-performance-ft-reports-2026-05-13/). Activist investor Converium Capital has urged CVS Group to improve performance and launch a £100 million share buyback. The report concerns investor pressure on the UK veterinary group.
- 13 May 2026, ft.com: [UK veterinary group CVS targeted by activist investor](https://www.ft.com/content/4e75d862-858f-4f3e-b9ba-17c3e139dbff). Converium Capital has built a 2% stake in CVS Group and is seeking a £100 million share buyback, with possible board action if it is ignored. The activist argues CVS remains undervalued after the CMA investigation concluded.

- [CVS Group deep dive](https://www.omniscan.ai/benchmarks/uk-veterinary-groups-2026-h1?entity=cvsgroup&view=deep-dive)
- [CVS Group PDF report](https://www.omniscan.ai/benchmarks/uk-veterinary-groups-2026-h1/reports/cvsgroup.pdf)

### IVC Evidensia

**IVC Evidensia’s subject mix shifted as visibility fluctuated**

IVC Evidensia ranked 2nd of 6 by average monthly share of coverage (25.0%) in the UK Veterinary Groups benchmark for H1 2026, with 89 mentions and a net tone of +20.

January combined specialist clinical work, including Kobi the cat’s complex heart procedure, with scrutiny of veterinary costs, client communication and the group’s response to BBC Panorama. February’s varied subject mix included the rollout of the inspiring vet care identity, investment in low-flow anaesthesia and the withdrawal of a planned debt extension. March brought the period’s largest volume, at 26 mentions, although share fell to 25.5% and rank to second; stories included the proposed closure of Great Western Exotics, a Pet Health Club trademark dispute and preparations for a possible flotation. Share and volume declined through April and May, reaching 8.4% and seven mentions in May. June returned IVC Evidensia to first with 36.7% of tracked-company mentions; stories included its RSPCA rehoming partnership, competition-probe expenditure and extensive hot-weather safety guidance. Visibility peaked in February 2026 at 39%, compared with 8.4% in May 2026. February 2026: IVC Evidensia set out its UK masterbrand strategy for inspiring vet care, reported by marketingweek.com. March 2026: concerns over the future of Great Western Exotics and access to specialist care were reported by theguardian.com. May 2026: IVC Evidensia-owned practices partially restored out-of-hours small-animal care in Moray, reported by northern-scot.co.uk.

Key messages:

- Visibility peaked in February 2026 at 39%, compared with 8.4% in May 2026.
- January 2026: Southern Counties Veterinary Specialists performed Kobi the cat’s complex heart procedure, reported by bbc.co.uk.
- IVC Evidensia has invested £500,000 in equipment and training to expand low-flow anaesthesia across its UK practices. The group says the approach can reduce emissions while maintaining or improving patient safety.
- IVC Evidensia has launched “inspiring vet care” as its unified UK endorsing brand, to be rolled out across more than 900 practices during 2026. The programme retains local clinic names while updating branding, communications and digital channels.
- IVC Evidensia is pursuing a UK masterbrand rebrand intended to improve client experience and support growth. Its marketing leadership aims to position the group as the UK’s leading veterinary care provider.
- IVC Evidensia and MSD Animal Health report sustainability initiatives across UK and European veterinary practices, including reusable surgical gowns and blister-pack recycling. The partnership is entering its third year.

Leading themes:

- Clinical Standards & Pet Safety: 39.3% of IVC Evidensia's coverage (theme index 2.27, net tone +69)
- CMA Remedies & Competition: 13.5% of IVC Evidensia's coverage (theme index 1.17, net tone −50)
- Practices, Acquisitions & Estate: 9.0% of IVC Evidensia's coverage (theme index 0.58, net tone −50)

Notable positive coverage:

- 10 February 2026, vetsurgeon.org: [IVC Evidensia invests £500,000 to support adoption of more sustainable low-flow anaesthesia](https://www.vetsurgeon.org/b/veterinary-news/posts/ivc-evidensia-invests-500-000-to-support-adoption-of-more-sustainable-low-flow-anaesthesia). IVC Evidensia has invested £500,000 in equipment and training to expand low-flow anaesthesia across its UK practices. The group says the approach can reduce emissions while maintaining or improving patient safety.
- 12 February 2026, vettimes.com: [IVC Evidensia unveils new branding for UK practices](https://www.vettimes.com/news/business/practice-developments/ivc-evidensia-unveils-new-branding-for-uk-practices). IVC Evidensia introduced its new UK operating brand, inspiring vet care, starting with Lime Tree Vets in Stoke-on-Trent. The group plans to complete the wider rollout of signage, materials and digital platforms by year-end.
- 13 February 2026, lbbonline.com: [IVC Evidensia Introduces New Unified UK Brand: inspiring vet care](https://lbbonline.com/news/IVC-Evidensia-Introduces-New-Unified-UK-Brand-inspiring-vet-care). IVC Evidensia has launched “inspiring vet care” as its unified UK endorsing brand, to be rolled out across more than 900 practices during 2026. The programme retains local clinic names while updating branding, communications and digital channels.

Notable negative coverage:

- 23 June 2026, ft.com: [Private equity-owned vet group IVC spends £34mn on UK competition probe](https://www.ft.com/content/05a0ed7c-ec9f-4344-92cd-904611076f89?syn-25a6b1a6=1). The Financial Times reports that IVC spent £34 million on the UK competition probe. The report concerns the group’s engagement with the veterinary-market investigation.
- 1 April 2026, vetsurgeon.org: [Whistleblower reveals corporate vet group's post-CMA price list](https://www.vetsurgeon.org/b/veterinary-news/posts/whistleblower-reveals-corporate-vet-group-s-post-cma-price-list). VetSurgeon reports an alleged IVC plan to introduce a premium "Pre-Scription" service ahead of CMA prescription-fee and price-transparency remedies. The article also describes an alleged draft price list.
- 30 March 2026, theguardian.com: [Reforms must be fair to vets and pet owners | Letters](https://www.theguardian.com/science/2026/mar/30/reforms-must-be-fair-to-vets-and-pet-owners). Letters discuss the CMA’s veterinary-market remedies, affordability and concerns about corporate ownership. One letter raises reduced services at IVC Evidensia’s Great Western Exotics referral hospital.

- [IVC Evidensia deep dive](https://www.omniscan.ai/benchmarks/uk-veterinary-groups-2026-h1?entity=ivcevidensia&view=deep-dive)
- [IVC Evidensia PDF report](https://www.omniscan.ai/benchmarks/uk-veterinary-groups-2026-h1/reports/ivcevidensia.pdf)

### VetPartners

**VetPartners’ visibility reflected company-focused operational developments and sector scrutiny**

VetPartners ranked 3rd of 6 by average monthly share of coverage (16.9%) in the UK Veterinary Groups benchmark for H1 2026, with 57 mentions and a net tone of +75.

March was the low point at 6.9%, when four of its seven mentions were contextual coverage of CMA remedies rather than company-focused developments. April’s 25.0% share coincided with Tim Shearman’s appointment as UK managing director, a reported 65% reduction in antibiotic purchasing per full-time-equivalent vet between 2021 and 2025, and investment in Clifton Lodge Vets’ Hartlepool centre. After falling to 9.6% in May, share reached 28.6% in June alongside stories about rural access through Ashlands Veterinary Centre’s pop-up clinic, practice refurbishment, preventative care and Vetlife fundraising. Visibility peaked in June 2026 at 28.6%, compared with 6.9% in March 2026. January 2026: New Era Veterinary Hospital treated a cold-stunned loggerhead turtle with round-the-clock care, reported by Vet Times. March 2026: share fell 7.7 points to 6.9% and rank moved from third to fourth; stories included Rutland House Vets opening a consolidated Haydock practice. April 2026: share rose 18.1 points to 25.0% and rank moved to second; VetPartners appointed Tim Shearman as UK managing director. February 2026: the BBC reported a couple’s £5,600 bill for complex puppy treatment at Wood Veterinary Group. May 2026: Vet Times covered VetPartners’ veterinary-nursing roundtable on career progression and professional reform.

Key messages:

- Visibility peaked in June 2026 at 28.6%, compared with 6.9% in March 2026.
- January 2026: New Era Veterinary Hospital treated a cold-stunned loggerhead turtle with round-the-clock care, reported by Vet Times.
- Auchentiber Farm was named runner-up in VetPartners' inaugural Farm Health Awards. The awards recognise farmers' animal-health, sustainability and veterinary-collaboration work.
- VetPartners raised a record £376,453 for 138 charities and causes in 2025. It also raised funds for Vetlife, its chosen charity for 2026.
- VetPartners appoints Tim Shearman as UK managing director to lead its UK operations from York. The group says the appointment supports further growth and its people-focused culture.
- VetPartners reports that UK antibiotic purchasing per full-time-equivalent vet fell 65% from 2021 to 2025. Its annual clinical report also details antimicrobial stewardship and quality-improvement activity.

Leading themes:

- Other: 28.1% of VetPartners's coverage (theme index 6.56, net tone +94)
- Practices, Acquisitions & Estate: 19.3% of VetPartners's coverage (theme index 1.47, net tone +82)
- Clinical Standards & Pet Safety: 19.3% of VetPartners's coverage (theme index 0.84, net tone +91)

Notable positive coverage:

- 15 January 2026, greenocktelegraph.co.uk: [Farm near Kilmacolm recognised at inaugural VetPartners Farm Health Awards](https://www.greenocktelegraph.co.uk/news/25765181.auchentiber-farm-praised-animal-health-innovation/). Auchentiber Farm was named runner-up in VetPartners' inaugural Farm Health Awards. The awards recognise farmers' animal-health, sustainability and veterinary-collaboration work.
- 22 January 2026, vettimes.com: [VetPartners celebrates record fund-raising year for 2025](https://www.vettimes.com/news/vets/wellbeing-at-work/vetpartners-celebrates-record-fund-raising-year-for-2025). VetPartners raised a record £376,453 for 138 charities and causes in 2025. It also raised funds for Vetlife, its chosen charity for 2026.
- 7 April 2026, yorkshirepost.co.uk: [VetPartners: Tim Shearman takes helm as York-based UK managing director](https://www.yorkshirepost.co.uk/business/vetpartners-tim-shearman-takes-helm-as-york-based-uk-managing-director-6565140). VetPartners appoints Tim Shearman as UK managing director to lead its UK operations from York. The group says the appointment supports further growth and its people-focused culture.

Notable negative coverage:

- 5 May 2026, yorkpress.co.uk: [Well-known York vet practice announces closure 'with a heavy heart'](https://www.yorkpress.co.uk/news/26078331.minster-equine-vets-poppleton-york-set-close/). VetPartners-owned Minster Equine Veterinary Clinic in York will permanently close on 15 May 2026, citing complex factors. Nearby VetPartners practices are to support continuity of care.

- [VetPartners deep dive](https://www.omniscan.ai/benchmarks/uk-veterinary-groups-2026-h1?entity=vetpartners&view=deep-dive)
- [VetPartners PDF report](https://www.omniscan.ai/benchmarks/uk-veterinary-groups-2026-h1/reports/vetpartners.pdf)

### Pets at Home Vet Group

**Vet growth and expansion underpin a volatile third-place profile**

Pets at Home Vet Group ranked 4th of 6 by average monthly share of coverage (16.5%) in the UK Veterinary Groups benchmark for H1 2026, with 74 mentions and a net tone of +72.

January brought first place with a 32.3% share amid reporting of 5% veterinary revenue growth, maintained profit guidance, estate plans and the Harlow store fire. Visibility then fell to fifth place and 2.4% in February, when the sole captured development was Barnsley’s surgery on a cat with a rare brain tumour. March recovered to third place and 19.6%; stories included a £3 million investment in four locations, new Vets for Pets practices and reaffirmed profit expectations. April’s smaller agenda combined the treatment of a cat that swallowed 37 hair bands, Cardiff expansion approval and a Kidderminster price increase before May reached second place and 31.3% alongside full-year results showing veterinary revenue and profit growth. Visibility peaked in January 2026 at 32.3%, compared with 2.4% in February 2026. January 2026: The Independent reported that 5% veterinary sales growth helped offset weaker retail trading. May 2026: share rose 22.2 percentage points to 31.3% and rank improved to second; full-year reporting included 5% veterinary consumer-revenue growth, 10.4% underlying-profit growth and estate expansion. June 2026: share fell 27.2 percentage points to 4.1% and rank moved to fifth; the BBC reported the Northampton practice’s relocation after the 2025 fire. A fire at Pets at Home's Harlow store also affected its co-located Vets for Pets practice. All animals were rescued and the practice's reopening date remains under assessment.

Key messages:

- Visibility peaked in January 2026 at 32.3%, compared with 2.4% in February 2026.
- January 2026: The Independent reported that 5% veterinary sales growth helped offset weaker retail trading.
- A new purpose-built Vets for Pets practice is due to open at Fox Valley in Stocksbridge. The clinic will offer routine and diagnostic services, surgery, pharmacy and dedicated animal wards.
- Pets at Home reported that Vets for Pets veterinary-services revenue rose 5% in the third quarter. The wider group expected full-year underlying earnings to meet expectations despite weaker retail revenue.
- Reuters reports Pets at Home's veterinary business delivered strong growth while retail recovery efforts resumed. The company's underlying pre-tax profit fell 30.2%, chiefly reflecting soft retail earnings.
- Pets at Home reported that revenue in its veterinary arm rose 5% despite a 28% fall in group annual profit, driven primarily by retail pressures. The new chief executive highlighted the group’s recovery potential.

Leading themes:

- Financial Results & Ownership: 58.1% of Pets at Home Vet Group's coverage (theme index 4.19, net tone +86)
- Practices, Acquisitions & Estate: 21.6% of Pets at Home Vet Group's coverage (theme index 1.76, net tone +63)
- CMA Remedies & Competition: 6.8% of Pets at Home Vet Group's coverage (theme index 0.51, net tone +40)

Notable positive coverage:

- 13 March 2026, thestar.co.uk: [Vets for Pets practice to open at Fox Valley](https://www.thestar.co.uk/business/vets-for-pets-practice-to-open-at-fox-valley-5708646). A new purpose-built Vets for Pets practice is due to open at Fox Valley in Stocksbridge. The clinic will offer routine and diagnostic services, surgery, pharmacy and dedicated animal wards.
- 28 January 2026, sharecast.com: [FTSE 250 movers: Pets at Home jumps, miners shine](https://www.sharecast.com/news/risers-and-fallers/ftse-250-movers--21565550.html). Pets at Home reported that Vets for Pets veterinary-services revenue rose 5% in the third quarter. The wider group expected full-year underlying earnings to meet expectations despite weaker retail revenue.
- 28 January 2026, lse.co.uk: [Pets at Home sees FY in line as third-quarter revenue falls](https://www.lse.co.uk/news/pets-at-home-sees-fy-in-line-as-third-quarter-revenue-falls-6ij0k0olk9htps3.html). Pets at Home said Vets for Pets veterinary-services revenue rose 5% in the third quarter. The article also notes wider scrutiny of veterinary pricing and proposed CMA measures.

Notable negative coverage:

- 9 June 2026, bbc.com: [Northampton pet shop reflects on 'devastating' fire anniversary](https://www.bbc.com/news/articles/cqx1rnlpn1po). A Vets for Pets surgery in Northampton is relocating after a 2025 fire destroyed its premises within a Pets at Home outlet. The practice had been operating temporarily and is moving to Sixfields Retail Park.
- 21 January 2026, vettimes.com: [Vet practice appeals for return of 'vital' pet ambulance stolen for second time](https://www.vettimes.com/news/business/practice-developments/vet-practice-appeals-for-return-of-vital-pet-ambulance-stolen-for-second-time). Vets for Pets Bournemouth appeals for the return of its stolen pet ambulance, saying the theft has impaired home visits, charity support and animal transport. Police enquiries are ongoing.
- 15 April 2026, kidderminstershuttle.co.uk: [Vets announces price increases due to 'current inflation costs'](https://www.kidderminstershuttle.co.uk/news/26007528.prices-increase-kidderminster-vet-due-inflation-costs/). Vets for Pets Central Kidderminster increased prices, citing inflationary operating costs. The practice said changes support investment in teams, facilities and clinical standards.

- [Pets at Home Vet Group deep dive](https://www.omniscan.ai/benchmarks/uk-veterinary-groups-2026-h1?entity=petsathomevetgroup&view=deep-dive)
- [Pets at Home Vet Group PDF report](https://www.omniscan.ai/benchmarks/uk-veterinary-groups-2026-h1/reports/petsathomevetgroup.pdf)

### Medivet

**Medivet rose to third as ownership and clinical stories broadened**

Medivet ranked 5th of 6 by average monthly share of coverage (10.4%) in the UK Veterinary Groups benchmark for H1 2026, with 38 mentions and a net tone of +26.

Its monthly share began at 6.2% in fifth place in January, when stories included the planned transition to locally co-owned practices, winter pet-safety guidance and analysis of popular pet names. February brought fourth place on 9.8%, alongside the Medivet and Partners rebrand and warnings about viral dog treats and toxic flowers, foods and raw-meat risks. In March, share fell to 4.9% and fifth place despite volume increasing to five; four of those five measured references were contextual coverage of veterinary-market reforms, while the company-focused story concerned emergency treatment after a dog attack. Share then rose to 13.6% in April and 15.7% in May, moving Medivet from fourth to third as coverage combined its partnership model, compassionate euthanasia guidance, treatment and rehoming of an injured puppy, and repeated reporting about former Skeldale partners’ departures. May also included Medivet’s report that 65% of practices were partner-led and its aim for full partner leadership by the end of 2026. June’s 12.2% share and fourth place coincided with the sale of 50 Spanish practices to VetPartners and stories on heatwave, grass-seed and event-noise safety. Visibility peaked in May 2026 at 15.7%, compared with 4.9% in March 2026.

Key messages:

- Visibility peaked in May 2026 at 15.7%, compared with 4.9% in March 2026.
- January 2026: Medivet set out its plan for all UK practices to be locally co-owned and clinician-led in Vet Times.
- Medivet says it expects all UK practices to be co-owned and led by local clinician partners by the start of next year. The company presents the model as increasing local autonomy and ownership while retaining national clinical governance.
- Medivet has launched its Medivet and Partners branding while progressing plans for UK practices to be co-owned and led by local partners. Initial branded practices are in Newton-le-Willows and Parsons Green.
- Medivet has agreed to sell 50 Spanish practices to VetPartners, subject to Spanish regulatory approval. Medivet says the disposal will concentrate capital and leadership on UK growth and its partnership model.
- Medivet clinical governance director Dr Rhian Littlehales provides heatwave safety guidance for pet owners, including recognising and responding to heatstroke. The article presents Medivet as a source of clinical advice.

Leading themes:

- Clinical Standards & Pet Safety: 44.7% of Medivet's coverage (theme index 2.24, net tone +76)
- Practices, Acquisitions & Estate: 28.9% of Medivet's coverage (theme index 2.33, net tone −82)
- CMA Remedies & Competition: 10.5% of Medivet's coverage (theme index 0.87, net tone +25)

Notable positive coverage:

- 16 January 2026, vettimes.com: [Medivet boss hails 'new direction' with practice ownership model](https://www.vettimes.com/news/business/practice-developments/medivet-boss-hails-new-direction-with-practice-ownership-model). Medivet says it expects all UK practices to be co-owned and led by local clinician partners by the start of next year. The company presents the model as increasing local autonomy and ownership while retaining national clinical governance.
- 10 February 2026, vettimes.com: [New look unveiled for Medivet and Partners](https://www.vettimes.com/news/business/practice-developments/new-look-unveiled-for-medivet-and-partners). Medivet has launched its Medivet and Partners branding while progressing plans for UK practices to be co-owned and led by local partners. Initial branded practices are in Newton-le-Willows and Parsons Green.
- 14 May 2026, vettimes.com: [Medivet aiming to have 100% of its practices partner-led by end of 2026](https://www.vettimes.com/news/vet-nursing/wellbeing-at-work-vet-nursing/medivet-reveals-65-partner-led-status). Medivet says 65% of its practices were partner-led at the end of financial year 2026, up from 40% a year earlier. It aims for all practices to be partner-led by the end of 2026, supported by new network teams and leadership development.

Notable negative coverage:

- 15 May 2026, express.co.uk: [Yorkshire Vet's Peter Wright says 'I'm beyond those days' in career admission](https://www.express.co.uk/showbiz/tv-radio/2206122/yorkshire-vet-peter-wright-career-admission). Peter Wright said Skeldale's takeover by Medivet changed his role and contributed to his decision to stop doing work he loved. The article otherwise covers a Yorkshire Vet night-shift episode.
- 15 May 2026, mirror.co.uk: [Yorkshire Vet's Peter Wright makes candid career admission after Skeldale exit](https://www.mirror.co.uk/tv/tv-news/yorkshire-vet-star-peter-wrights-37162911). Peter Wright says he left Skeldale Veterinary Centre after its acquisition by Medivet, which ended his ability to continue farm work. The article frames the takeover as making that work economically unviable.
- 3 May 2026, mirror.co.uk: [Julian Norton speaks on on 'lonely' vet work and Peter Wright's Skeldale exit](https://www.mirror.co.uk/tv/tv-news/yorkshire-vets-julian-norton-lonely-37103771). Former Skeldale Veterinary Centre partner Peter Wright says Medivet's acquisition led to the removal of farm work he valued, contributing to his departure. The article also discusses Julian Norton's comments on the isolation of veterinary work.

- [Medivet deep dive](https://www.omniscan.ai/benchmarks/uk-veterinary-groups-2026-h1?entity=medivet&view=deep-dive)
- [Medivet PDF report](https://www.omniscan.ai/benchmarks/uk-veterinary-groups-2026-h1/reports/medivet.pdf)

### Linnaeus

**Linnaeus visibility centred on sector reform and one clinical development**

Linnaeus ranked 6th of 6 by average monthly share of coverage (1.6%) in the UK Veterinary Groups benchmark for H1 2026, with 7 mentions and a net tone of −14.

January’s single mention was contextual: BBC Panorama examined commercial pressure, pricing transparency and the competition inquiry across major veterinary groups. Coverage rose from zero in February to four mentions and a 3.9% share in March. Following no coverage in April or May, June produced the only captured company-focused development: Vet Times reported Bristol Vet Specialists’ relaunch of cell transplantation for dogs with severe spinal injuries, while a BBC report on rising bills separately included comments from Southfields Veterinary Specialists. Visibility peaked in June 2026 at 4.1%, compared with 0% in February 2026. Bristol Vet Specialists has relaunched olfactory ensheathing cell transplantation for dogs with severe spinal cord injuries and is recruiting suitable dogs for ongoing research. The treatment may improve mobility for some paralysed dogs but is not presented as a cure. The CMA’s veterinary-market reforms cap written prescription fees, require price transparency and ownership disclosure, and introduce a comparison service. The inquiry says large groups generally have higher prices and some acquisitions increased prices, while several groups respond to the remedies. Several large veterinary groups reacted positively or constructively to the CMA’s final reforms. CVS said the remedies were workable despite reservations, while Vets for Pets and Medivet highlighted aspects of the findings favourable to their models.

Key messages:

- Visibility peaked in June 2026 at 4.1%, compared with 0% in February 2026.
- Bristol Vet Specialists has relaunched olfactory ensheathing cell transplantation for dogs with severe spinal cord injuries and is recruiting suitable dogs for ongoing research. The treatment may improve mobility for some paralysed dogs but is not presented as a cure.
- BBC Panorama examines allegations that corporate veterinary groups, particularly IVC Evidensia, create commercial pressure on vets and contribute to high, unclear pet-care bills. It also covers the CMA investigation into competition, ownership and pricing transparency across the six large veterinary groups.
- The CMA’s veterinary-market reforms cap written prescription fees, require price transparency and ownership disclosure, and introduce a comparison service. The inquiry says large groups generally have higher prices and some acquisitions increased prices, while several groups respond to the remedies.

Leading themes:

- CMA Remedies & Competition: 57.1% of Linnaeus's coverage (theme index 5.13, net tone −50)
- Pricing, Fees & Transparency: 28.6% of Linnaeus's coverage (theme index 5.13, net tone 0)
- Clinical Standards & Pet Safety: 14.3% of Linnaeus's coverage (theme index 0.63, net tone +100)

Notable positive coverage:

- 24 June 2026, vettimes.com: [Bristol Vet Specialists relaunches pioneering cell transplant spinal treatment](https://www.vettimes.com/news/business/practice-developments/bristol-vet-specialists-relaunches-pioneering-cell-transplant-spinal-treatment). Bristol Vet Specialists has relaunched olfactory ensheathing cell transplantation for dogs with severe spinal cord injuries and is recruiting suitable dogs for ongoing research. The treatment may improve mobility for some paralysed dogs but is not presented as a cure.

- [Linnaeus deep dive](https://www.omniscan.ai/benchmarks/uk-veterinary-groups-2026-h1?entity=linnaeus&view=deep-dive)
- [Linnaeus PDF report](https://www.omniscan.ai/benchmarks/uk-veterinary-groups-2026-h1/reports/linnaeus.pdf)

## Methodology

- **Share of coverage**: an organisation's mentions divided by all mentions of the organisations tracked in the same sector that month, in UK earned media. It is the central measure of media visibility in Omniscan benchmarks. "Average monthly share" is the mean of the monthly shares across the reporting period.
- **Mention**: one article that covers an organisation, classified as positive, neutral or negative in tone. Articles are deduplicated, and an organisation's own websites and passing sponsorship name-checks are excluded, so only earned media counts.
- **Net tone**: positive mentions minus negative mentions, as a percentage of all mentions (range −100 to +100).
- **Themes**: every article is assigned to one of the sector's editorial themes. A theme index above 1 means the organisation is covered on that theme more than its peers are; below 1 means less.
- **Calculation**: every figure is computed directly from the classified articles; narrative summaries are checked against those figures.
- **Sources**: UK national and international, trade and specialist, regional and local, and aggregator and syndication earned media.

## Other UK Veterinary Groups editions

- [UK veterinary groups media reputation tracker – 2026 year to date](https://www.omniscan.ai/benchmarks/uk-veterinary-groups-2026-ytd.md)
- [UK veterinary groups media reputation tracker – July 2026](https://www.omniscan.ai/benchmarks/uk-veterinary-groups-2026-07.md)
- [UK veterinary groups media reputation tracker – August 2026](https://www.omniscan.ai/benchmarks/uk-veterinary-groups-2026-08.md)
- [UK veterinary groups media reputation tracker – September 2026](https://www.omniscan.ai/benchmarks/uk-veterinary-groups-2026-09.md)
- [All Omniscan media benchmarks](https://www.omniscan.ai/benchmarks.md)

## How to cite

Omniscan, "UK veterinary groups media reputation tracker", H1 2026 (1 January 2026–30 June 2026), published 1 September 2026. https://www.omniscan.ai/benchmarks/uk-veterinary-groups-2026-h1